Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo S Fiandaca

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 12, 2022
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 21, 2025
Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson's DiseaseAmber D Van Laar, Chadwick W Christine, Nicolás Phielipp, et al.
Frontiers in Neurology|December 1, 2015
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's DiseaseMassimo S Fiandaca, Xiaogang Zhong, Amrita K Cheema, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 24, 2011
Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's diseaseR Mark Richardson, Adrian P Kells, Kathryn H Rosenbluth, et al.
Geroscience|May 18, 2022
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's diseaseFabio Macciardi, Maria Giulia Bacalini, Ricardo Miramontes, et al.
Human Gene Therapy|March 13, 2014
Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophyMarco A Passini, Jie Bu, Amy M Richards, et al.
Journal of Parkinson'S Disease|February 17, 2025
Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshopRoger A Barker, Mart Saarma, Clive N Svendsen, et al.
Frontiers in Human Neuroscience|May 15, 2015
Critical periods after stroke study: translating animal stroke recovery experiments into a clinical trialAlexander W Dromerick, Matthew A Edwardson, Dorothy F Edwards, et al.
Cancers|December 24, 2021
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDACMeena U Rajagopal, Shivani Bansal, Prabhjit Kaur, et al.
Nature Medicine|March 11, 2014
Plasma phospholipids identify antecedent memory impairment in older adultsMark Mapstone, Amrita K Cheema, Massimo S Fiandaca, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 12, 2022
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's diseaseMatthew T Rocco, Asad S Akhter, Debra J Ehrlich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 21, 2025
Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson's DiseaseAmber D Van Laar, Chadwick W Christine, Nicolás Phielipp, et al.
Frontiers in Neurology|December 1, 2015
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's DiseaseMassimo S Fiandaca, Xiaogang Zhong, Amrita K Cheema, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 24, 2011
Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's diseaseR Mark Richardson, Adrian P Kells, Kathryn H Rosenbluth, et al.
Geroscience|May 18, 2022
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's diseaseFabio Macciardi, Maria Giulia Bacalini, Ricardo Miramontes, et al.
Human Gene Therapy|March 13, 2014
Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophyMarco A Passini, Jie Bu, Amy M Richards, et al.
Journal of Parkinson'S Disease|February 17, 2025
Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshopRoger A Barker, Mart Saarma, Clive N Svendsen, et al.
Frontiers in Human Neuroscience|May 15, 2015
Critical periods after stroke study: translating animal stroke recovery experiments into a clinical trialAlexander W Dromerick, Matthew A Edwardson, Dorothy F Edwards, et al.
Cancers|December 24, 2021
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDACMeena U Rajagopal, Shivani Bansal, Prabhjit Kaur, et al.
Nature Medicine|March 11, 2014
Plasma phospholipids identify antecedent memory impairment in older adultsMark Mapstone, Amrita K Cheema, Massimo S Fiandaca, et al.
Pageof 5